Literature DB >> 1633640

Birth prevalence studies of the Crouzon syndrome: comparison of direct and indirect methods.

M M Cohen1, S Kreiborg.   

Abstract

An indirect method for estimating the birth prevalence of the Crouzon syndrome is presented. The fraction of Crouzon syndrome patients in large clinical surveys of all cases of craniosynostosis is calculated and the fractional component obtained is multiplied by the known birth prevalence of craniosynostosis in general. Crouzon syndrome makes up approximately 4.8% of all cases of craniosynostosis. Using a weighted average estimate, birth prevalence was calculated to be 16.5/1,000,000. The results of the indirect method compare favorably with those obtained by the direct method. Nevertheless, because the indirect method is based on a number of assumptions that are easily violated, we cannot recommend its general use except under special circumstances.

Entities:  

Mesh:

Year:  1992        PMID: 1633640     DOI: 10.1111/j.1399-0004.1992.tb03620.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  30 in total

1.  Sleep-disordered breathing in children with craniosynostosis.

Authors:  Muslim M Alsaadi; Shaikh M Iqbal; Essam A Elgamal; Mustafa A Salih; David Gozal
Journal:  Sleep Breath       Date:  2012-04-26       Impact factor: 2.816

2.  Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.

Authors:  K Shen; S M Krakora; M Cunningham; M Singh; X Wang; F Z Hu; J C Post; G D Ehrlich
Journal:  Orthod Craniofac Res       Date:  2009-08       Impact factor: 1.826

3.  A Crouzon syndrome from the Classic period of Maya civilization?

Authors:  Patricia Deps; Philippe Charlier
Journal:  Surg Radiol Anat       Date:  2019-07-26       Impact factor: 1.246

4.  Crouzon Syndrome: Report in a Family.

Authors:  Dhanya S Kumar; Devaki Murugesan; Kandasamy Murugan; Divya Subramanian; S Uma Maheshwari
Journal:  J Clin Diagn Res       Date:  2016-01-01

5.  Review Article: Chiari Type I Malformation with or Without Syringomyelia: Prevalence and Genetics.

Authors:  Marcy C Speer; David S Enterline; Lorraine Mehltretter; Preston Hammock; Judith Joseph; Margaret Dickerson; Richard G Ellenbogen; Thomas H Milhorat; Michael A Hauser; Timothy M George
Journal:  J Genet Couns       Date:  2003-08       Impact factor: 2.537

6.  A model for the pharmacological treatment of crouzon syndrome.

Authors:  Chad A Perlyn; Gillian Morriss-Kay; Tron Darvann; Marissa Tenenbaum; David M Ornitz
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

7.  Evidence that the Saethre-Chotzen syndrome locus lies between D7S664 and D7S507, by genetic analysis and detection of a microdeletion in a patient.

Authors:  A F Lewanda; E D Green; J Weissenbach; H Jerald; E Taylor; M L Summar; J A Phillips; M Cohen; M Feingold; W Mouradian
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

Review 8.  Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.

Authors:  Anna Kutkowska-Kaźmierczak; Monika Gos; Ewa Obersztyn
Journal:  J Appl Genet       Date:  2018-02-01       Impact factor: 3.240

9.  Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes.

Authors:  Yann Heuzé; Neus Martínez-Abadías; Jennifer M Stella; Eric Arnaud; Corinne Collet; Gemma García Fructuoso; Mariana Alamar; Lun-Jou Lo; Simeon A Boyadjiev; Federico Di Rocco; Joan T Richtsmeier
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

10.  Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.

Authors:  Jin Liu; Hwa Kyung Nam; Estee Wang; Nan E Hatch
Journal:  Calcif Tissue Int       Date:  2013-01-29       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.